Published in Heart Rhythm on January 17, 2008
Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation. Circ Res (2011) 1.82
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.21
In search of the sources of cardiac fibrillation. EMBO Mol Med (2010) 1.10
New pharmacological strategies for the treatment of atrial fibrillation. Ann Noninvasive Electrocardiol (2009) 1.02
Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery. Heart Rhythm (2009) 1.00
Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther (2011) 0.94
The Na+/K+ pump is an important modulator of refractoriness and rotor dynamics in human atrial tissue. Am J Physiol Heart Circ Physiol (2011) 0.94
Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.92
Transient outward K+ current reduction prolongs action potentials and promotes afterdepolarisations: a dynamic-clamp study in human and rabbit cardiac atrial myocytes. J Physiol (2012) 0.89
Gender differences in electrophysiological gene expression in failing and non-failing human hearts. PLoS One (2013) 0.89
Pro-arrhythmogenic effects of the S140G KCNQ1 mutation in human atrial fibrillation - insights from modelling. J Physiol (2012) 0.86
In silico screening of the key cellular remodeling targets in chronic atrial fibrillation. PLoS Comput Biol (2014) 0.84
Ion Channels in the Heart. Compr Physiol (2015) 0.83
Novel pharmacological targets for the rhythm control management of atrial fibrillation. Pharmacol Ther (2011) 0.83
Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade. Pflugers Arch (2011) 0.82
Effects of human atrial ionic remodelling by β-blocker therapy on mechanisms of atrial fibrillation: a computer simulation. Europace (2014) 0.81
Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation. Cardiovasc Res (2013) 0.80
Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times? Cardiovasc Res (2009) 0.79
Effects of selective mineralocorticoid receptor antagonism on atrial ion currents and early ionic tachycardia-induced electrical remodelling in rabbits. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.78
Mechanisms of postcardiac surgery atrial fibrillation: more pieces in a difficult puzzle. Heart Rhythm (2009) 0.77
A Computer Simulation Study of Anatomy Induced Drift of Spiral Waves in the Human Atrium. Biomed Res Int (2015) 0.76
Ionic and substrate mechanism of atrial fibrillation: rotors and the exitación frequency approach. Arch Cardiol Mex (2010) 0.75
Do hypoxemia or hypercapnia predispose to atrial fibrillation in breathing disorders, and, if so, how? Heart Rhythm (2010) 0.75
Atrial Fibrillation: The Science behind Its Defiance. Aging Dis (2016) 0.75
Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure. Clin Med Insights Cardiol (2016) 0.75
Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation (1995) 8.62
Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res (1999) 3.22
The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res (2001) 2.41
Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res (1999) 2.37
Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res (1997) 2.26
Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation (2005) 2.15
Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes. Circulation (2004) 1.97
Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J (2005) 1.96
L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation (2004) 1.85
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res (2003) 1.78
The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation (2005) 1.77
Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation (2005) 1.67
Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol (2006) 1.65
Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation (2004) 1.64
Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc Res (2003) 1.62
The L-type Ca2+-channel subunits alpha1C and beta2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation. J Mol Cell Cardiol (2003) 1.54
Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. J Mol Cell Cardiol (2003) 1.54
Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation. J Mol Cell Cardiol (2006) 1.53
Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation (2001) 1.37
Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans. Cardiovasc Res (2005) 1.36
Genes and atrial fibrillation: a new look at an old problem. Circulation (2007) 1.33
Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc Res (1999) 1.17
Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res (2002) 1.15
Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium. J Physiol (2004) 1.14
Triggered activity and atrial fibrillation. Heart Rhythm (2006) 1.10
Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure. Circulation (2004) 1.09
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. Cardiovasc Res (2007) 1.06
Atrial tachycardia remodeling of pulmonary vein cardiomyocytes: comparison with left atrium and potential relation to arrhythmogenesis. Circulation (2005) 1.05
Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol (2006) 1.03
Alterations in muscarinic K+ channel response to acetylcholine and to G protein-mediated activation in atrial myocytes isolated from failing human hearts. Circulation (1994) 1.02
The ultrarapid and the transient outward K(+) current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation. J Mol Cell Cardiol (2000) 1.01
Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation. J Cardiovasc Electrophysiol (2000) 1.00
Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol (1995) 0.97
Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.94
Increased open probability of single cardiac L-type calcium channels in patients with chronic atrial fibrillation. role of phosphatase 2A. Cardiovasc Res (2003) 0.94
Alterations in ATP-sensitive potassium channel sensitivity to ATP in failing human hearts. Am J Physiol (1997) 0.93
L-type calcium currents in atrial myocytes from patients with persistent and non-persistent atrial fibrillation. Basic Res Cardiol (2001) 0.93
Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade. Br J Pharmacol (2003) 0.92
Depressed transient outward and calcium currents in dilated human atria. Cardiovasc Res (1994) 0.92
Altered transient outward current in human atrial myocytes of patients with reduced left ventricular function. J Cardiovasc Electrophysiol (2000) 0.88
Comparison of calcium-current in isolated atrial myocytes from failing and nonfailing human hearts. Mol Cell Biochem (1996) 0.85
Remodeling of Ca(2+)-handling by atrial tachycardia: evidence for a role in loss of rate-adaptation. Cardiovasc Res (2002) 0.81
Changes of IK, ATP current density and allosteric modulation during chronic atrial fibrillation. Chin Med J (Engl) (2005) 0.80
Transient outward current in young and adult diseased human atria. Am J Physiol (1993) 0.77
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res (2003) 1.78
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Post-operative atrial fibrillation is influenced by beta-blocker therapy but not by pre-operative atrial cellular electrophysiology. J Cardiovasc Electrophysiol (2006) 1.65
Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc Res (2003) 1.62
Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation. J Mol Cell Cardiol (2006) 1.53
Targeting sphingosine-1-phosphate signalling for cardioprotection. Curr Opin Pharmacol (2008) 1.04
Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol (2006) 1.03
Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol (2003) 1.02
Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade. Br J Pharmacol (2003) 0.92
A web-based tool for teaching pharmacy practice competency. Am J Pharm Educ (2010) 0.85
Endothelin and the ischaemic heart. Curr Vasc Pharmacol (2005) 0.85
Junctional rhythm--a suitable surrogate endpoint in catheter ablation of atrioventricular nodal reentry tachycardia? Pacing Clin Electrophysiol (2005) 0.85
Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade. Pflugers Arch (2011) 0.82
Adrenomedullin acts via nitric oxide and peroxynitrite to protect against myocardial ischaemia-induced arrhythmias in anaesthetized rats. Br J Pharmacol (2006) 0.81
Apex-to-base dispersion of refractoriness underlies the proarrhythmic effect of hypokalaemia/hypomagnesaemia in the rabbit heart. J Electrocardiol (2002) 0.81
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. Br J Pharmacol (2010) 0.80
IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. J Mol Cell Cardiol (2008) 0.80
Electrophysiological effects of prucalopride, a novel enterokinetic agent, on isolated atrial myocytes from patients treated with beta-adrenoceptor antagonists. J Pharmacol Exp Ther (2005) 0.80
Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times? Cardiovasc Res (2009) 0.79
Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats. J Cardiovasc Pharmacol (2004) 0.77
Activation of protease activated receptor-2 induces delayed cardioprotection in anesthetized mice. Cardiovasc Drugs Ther (2009) 0.76
Do hypoxemia or hypercapnia predispose to atrial fibrillation in breathing disorders, and, if so, how? Heart Rhythm (2010) 0.75
Electrophysiological and haemodynamic effects of endothelin ETA and ETB receptors in normal and ischaemic working rabbit hearts. Br J Pharmacol (2005) 0.75
Localization of accessory pathways in the Wolff-Parkinson-White pattern--physician versus computer interpretation of the same algorithm. Pacing Clin Electrophysiol (2007) 0.75
Assessing stroke risk in patients with AF. Practitioner (2007) 0.75